Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2005-11-29
pubmed:abstractText
The mRNA processing body (P-body) is a cellular structure that regulates gene expression by degrading cytoplasmic mRNA. The objective of this study was to identify and characterize novel components of the mammalian P-body. Approximately 5% of patients with the autoimmune disease primary biliary cirrhosis have antibodies directed against this structure. Serum from one of these patients was used to identify a cDNA encoding Ge-1, a 1,401-amino-acid protein. Ge-1 contains an N-terminal WD 40 motif and C-terminal domains characterized by a repeating psi(X(2-3)) motif. Ge-1 co-localized with previously identified P-body components, including proteins involved in mRNA decapping (DCP1a and DCP2) and the autoantigen GW 182. The Ge-1 C-terminal domain was necessary and sufficient to target the protein to P-bodies. Following exposure of cells to oxidative stress, Ge-1-containing P-bodies were found adjacent to TIA-containing stress granules. During the recovery period, TIA returned to the nucleus while Ge-1-containing P-bodies localized to the perinuclear region. siRNA-mediated knock-down of Ge-1 resulted in loss of P-bodies containing Ge-1, DCP1a, and DCP2. In contrast, Ge-1-containing P-bodies persisted despite knock-down of DCP2. Taken together, the results of this study show that Ge-1 is a central component of P-bodies and suggest that Ge-1 may act prior to the 5(')-decapping step in mRNA degradation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-10322433, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-10747033, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-11751054, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-11780629, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-12440955, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-12730603, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-13130130, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-14598044, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-14749774, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-15067023, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-15152089, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-15189161, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-15340168, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-15494374, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-15625657, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-15731006, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-15742439, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-15840819, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-15967811, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-3047011, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-6219389, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-7520377, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-8900092, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-9067524, http://linkedlifedata.com/resource/pubmed/commentcorrection/16314453-9592163
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1355-8382
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1795-802
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:16314453-Amino Acid Motifs, pubmed-meshheading:16314453-Amino Acid Sequence, pubmed-meshheading:16314453-Antibodies, pubmed-meshheading:16314453-Autoantigens, pubmed-meshheading:16314453-Cell Line, Tumor, pubmed-meshheading:16314453-Cytoplasmic Structures, pubmed-meshheading:16314453-Fluorescent Antibody Technique, Indirect, pubmed-meshheading:16314453-Fluorescent Dyes, pubmed-meshheading:16314453-Humans, pubmed-meshheading:16314453-Immunohistochemistry, pubmed-meshheading:16314453-Indoles, pubmed-meshheading:16314453-Liver Cirrhosis, Biliary, pubmed-meshheading:16314453-Nuclear Proteins, pubmed-meshheading:16314453-Oxidative Stress, pubmed-meshheading:16314453-Protein Structure, Tertiary, pubmed-meshheading:16314453-Proteins, pubmed-meshheading:16314453-RNA, Messenger, pubmed-meshheading:16314453-RNA, Small Interfering, pubmed-meshheading:16314453-RNA Caps, pubmed-meshheading:16314453-Serine
pubmed:year
2005
pubmed:articleTitle
Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body.
pubmed:affiliation
Department of Medicine, Havard Medical School, the Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, Charlestown, MA 02129, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural